touchIMMUNOLOGY

🔎 What does long-term cancer risk look like for people diagnosed with inflammatory bowel disease (IBD) during childhood? At UEG Week 2026, Dr Karl Mårild (University of Gothenburg) discusses findings from a nationwide study involving approximately 12,000 patients with pediatric-onset IBD and 120,000 matched comparators. In this interview, Dr Mårild explores what the findings mean for patients and families, the potential implications for childhood cancer surveillance, and why international research is needed to guide long-term monitoring strategies. 🔗 Watch the full interview: touchimmunology.com/insight/… #UEGWeek2026 #IBD #PediatricIBD #CancerRisk #Gastroenterology

🩺 How can education and consensus-based guidance strengthen specialist inflammatory bowel disease (IBD) nursing? At UEG Week 2026, Simona Radice (Humanitas Clinical and Research IRCCS, Milan, Italy) and Tobias Mooslechner (President of CED-Nursing Austria) discuss the evolving role of IBD nurses and the importance of translating recommendations into everyday clinical practice. In this joint interview, they explore the latest N-ECCO consensus, the IBD nurse curriculum, key gaps in specialist nursing education, and the practical challenges of embedding evidence-based standards into multidisciplinary care. Discover how continued education and clearer nursing competencies could help support more consistent, high-quality care for people living with IBD. 🔗 Watch the full interview: touchimmunology.com/insight/… #UEGWeek2026 #IBD #IBDNursing #CrohnsDisease #UlcerativeColitis #Gastroenterology

🔬 Early-life exposures and IBD risk: what can Scandinavian birth cohorts tell us? At #UEGWeek2026, Dr Karl Mårild (University of Gothenburg, Sweden) discussed how prospective Scandinavian birth cohorts are helping to clarify the link between early-life environmental factors and later inflammatory bowel disease (IBD) risk. 📊 Key takeaways: 🔹 Higher diet quality in early childhood and the teenage years was consistently associated with a lower risk of later IBD 🔹 Short breastfeeding duration was not associated with later IBD risk, an important finding to avoid unnecessary concern for parents 🔹 Children with the healthiest overall habits (physical activity, diet quality and healthy weight) had a lower risk of later IBD 🔹 Future research will need to combine environmental, genetic and biomarker data to understand individual risk 💡 The key message: Identifying potentially modifiable early-life habits could open new avenues for IBD prevention. 🎥 Watch the full interview with Dr Mårild on touchIMMUNOLOGY: ow.ly/6Ico51049jK #UEGWeek2026 #IBD #PediatricGastroenterology #Epidemiology #Gastroenterology #ClinicalResearch @my_ueg

🩺 The evolving role of the IBD nurse: From consensus to clinical practice At #UEGWeek2026, we spoke with Simona Radice (Humanitas Clinical and Research IRCCS, Milan, Italy) and Tobias Mooslechner (President, CED-Nursing Austria) after their joint nursing session with N-ECCO. 🔬 Key takeaways: 🔹 Specialist IBD nurses are increasingly central to multidisciplinary care, with a role extending well beyond treatment administration 🔹 The 3rd N-ECCO Consensus provides nursing guidance on advanced therapies, perioperative support, bowel urgency and incontinence, pain, reproductive health and inclusive care 🔹 How the IBD nurse curriculum and consensus guidance work together to define nursing competencies 🔹 Practical and organizational barriers still need addressing to implement standards into routine clinical practice Full interview available here: touchimmunology.com/insight/… #UEGWeek2026 #IBD #IBDNursing #NECCO #CrohnsDisease #UlcerativeColitis #Gastroenterology #NursingEducation

🩺 How is GSDIa managed today, and what do emerging therapies offer? Join Dr. David Rodriguez-Buritica as he explores current care, the daily burden of dietary therapy, and novel genetic and molecular approaches. 🎓 Watch & earn CME credit: touchimmunologyime.org/gsdia… #GSDIa #MedEd

Have you seen our latest #YouTube video? ‘The window of opportunity in hidradenitis suppurativa: Why timing and coordination matter’ Watch now: youtu.be/LXBDpgHjxoI #HidradenitisSuppurativa #HS #Dermatology #MedEd #CME #touchMDT

🎥 What was your biggest takeaway from UEG Week 2026? We asked experts across the congress to share the research, sessions, and clinical developments that stood out to them most. Now we want to hear from you. Which area made the biggest impression at #UEGWeek2026? 🔹 New IBD treatment data 🔹 Treat-to-target and disease monitoring 🔹 Microbiome and precision medicine 🔹 Emerging therapies and mechanisms Watch our speaker highlights here: touchimmunology.com/hub/ueg-… and let us know in the comments below 👇 #UEGWeek2026 #IBD #Gastroenterology #Immunology @my_ueg

🩺 Stay curious. Stay informed. Stay connected. Medicine never stands still and neither should your knowledge. Follow touchIMMUNOLOGY and make your feed a destination for trusted medical education, expert perspectives and the latest thinking across a wide range of therapy areas. Why follow us? 🎓 Keep up with expert-led medical education 🔬 Explore the latest clinical insights and developments 🎥 Hear directly from leading healthcare professionals 🌍 Connect with perspectives from across the global medical community 📚 Discover educational content designed to support your ongoing learning 🔔 Be among the first to see our latest videos, articles and expert discussions Your feed. More informed. Follow touchIMMUNOLOGY and stay connected to the conversations shaping medicine. #MedicalEducation #MedEd #HealthcareProfessionals #MedicalLearning #ClinicalEducation #Healthcare

Have you listened to our latest #Podcast? ‘The window of opportunity in hidradenitis suppurativa: Why timing and coordination matter’ Listen now: Part 1: touchpodcast.podbean.com/e/t… Part 2: touchpodcast.podbean.com/e/t… Part 3: touchpodcast.podbean.com/e/t… Part 4: touchpodcast.podbean.com/e/t… #HidradenitisSuppurativa #HS #Dermatology #MedEd #CME #touchMDT

🦴 Juvenile axial spondyloarthritis: what can we learn from adult disease? A new review explores the diagnosis and management of juvenile axial spondyloarthritis, highlighting the links between paediatric and adult forms of spondyloarthritis and the challenges of identifying axial involvement early. Key topics include: 🔍 Recognising axial disease in children and adolescents 📋 Current approaches to diagnosis and classification 🩺 Treatment strategies and disease monitoring 🔄 Similarities and differences between juvenile and adult disease Read the full review: touchimmunology.com/pediatri… #Rheumatology #Spondyloarthritis #AxialSpondyloarthritis #JuvenileArthritis #JIA

📢 Can modifying the early microbiome reduce food sensitisation after Cesarean birth? Emerging evidence suggests that Cesarean-delivered infants begin life with a different microbial profile, which may influence immune development and increase the risk of food sensitisation. In this interview, Dr Clemente discusses whether early exposure to maternal microbes could help shape the infant microbiome and potentially reduce allergy risk. 🔗 Read the full interview: touchimmunology.com/insight/… #AAAAI2026 #Immunology #Microbiome #AllergyPrevention #Paediatrics

🔬 Could understanding GSDIa pathophysiology support better management? Join Dr. Deeksha Bali as she explores glucose-6-phosphatase deficiency, key clinical features, and laboratory findings. 🎓 Watch now & earn CME credit: touchimmunologyime.org/gsdia… #GSDIa #MedEd

🫁 Real-world insights from a joint ILD clinic A study of 130 patients with interstitial lung disease (ILD), many associated with systemic autoimmune rheumatic diseases (SARDs), highlights the value of multidisciplinary care in the UK. 💡 This real-world experience emphasises the importance of collaboration, personalised therapy, and careful patient monitoring in managing ILD. Read the full review 👉 touchimmunology.com/rheumato… #InterstitialLungDisease #SARD #Rheumatology

How could innovative clinical trial designs help accelerate research in inflammatory bowel disease (IBD)? At UEG Week 2026, Dr Nurulamin Noor (University of Cambridge and Cambridge University Hospitals) discusses how master protocol platform trials and Bayesian statistics could help make IBD research more efficient and generate answers for patients and clinicians. 🎥 Watch the full interview to explore emerging approaches to clinical trial design: touchimmunology.com/insight/… #UEGWeek #IBD #ClinicalTrials

How can IBD nursing education and consensus recommendations translate into better everyday patient care? At UEG Week 2026, Simona Radice and Tobias Mooslechner discuss the evolving role of specialist inflammatory bowel disease (IBD) nurses, the importance of the N-ECCO consensus statements, and how education can help embed evidence-based recommendations into clinical practice. Watch the interview to explore key unmet needs, developing nursing competencies, and the practical challenges of implementing these standards across healthcare settings. 🎥 Watch the full interview: touchimmunology.com/insight/… #UEGWeek #IBD #Nursing #Immunology

🩸 Could CAR-T therapy help reset the immune system in refractory ITP? Early phase 1 data presented at EHA 2026 suggest BCMA-directed CAR-T therapy could offer a new approach for patients with heavily pretreated, refractory primary immune thrombocytopenia (ITP). Among four evaluable patients: 🔹 3 achieved complete response within 14 days 🔹 Drug-free remissions lasted 6–14 months 🔹 One patient achieved a delayed response before relapsing 🔹 No severe immune effector cell-associated toxicities were reported Beyond platelet recovery, translational analyses suggested broader immune reprogramming, including changes in B cells, plasma cells and T-cell compartments. Could “immune resetting” represent a new therapeutic strategy for chronic autoimmune haematological disorders? 📖 Read the full expert Q&A with Prof Heng Mei: touchimmunology.com/insight/… #ITP #CART #Immunology #Haematology #AutoimmuneDisease #EHA2026 #MedicalEducation

🔬 Could molecular imaging provide a new noninvasive biomarker for fibrosis in Crohn’s disease? At #UEGWeek2026, Dr Alexander Le Saint-Grant (University of Edinburgh, UK) discusses research exploring whether molecular imaging can help distinguish fibrosis from inflammation and quantify fibrotic activity. 🎥 Watch the expert interview to hear more about the evolving role of molecular imaging in Crohn’s disease: touchimmunology.com/insight/… #CrohnsDisease #IBD #Biomarkers #MolecularImaging #UEGWeek2026

🩺 HS care is evolving. As new treatment options emerge, coordinated multidisciplinary care is more important than ever. Explore the latest touchMDT discussion on current and emerging therapies, specialist collaboration, and medical - surgical approaches. 🎓 Earn CME credit: touchimmunologyime.org/?vide…

🧬 Targeted immunomodulation in rare disorders: Regulatory milestones and clinical insights Recent regulatory milestones highlight rapid progress in rare immunological diseases, including autoimmune, autoinflammatory, and primary immunodeficiency disorders. Advances in therapies that selectively modulate immune pathways are improving disease control, reducing side effects, and offering hope where few treatment options existed. Read more: touchimmunology.com/insight/… #RareDisease #Immunology #Immunotherapy #OrphanDrugs

🧬 How can advances in GSDIa care shape patient outcomes? Explore the pathophysiology, management challenges, emerging therapies, and multidisciplinary care with leading experts in our touchEXPERT FOCUS. 🎓 Watch now & earn CME credit: touchimmunologyime.org/gsdia… #GSDIa #MedEd